Global Antibody-drug Conjugate Market Growth 2018-2023

October 2018 | 136 pages | ID: G62C846DD88EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Antibody-drug conjugates or ADCs are an important class of highly potent biopharmaceutical drugsdesigned as a targeted therapy for the treatment of people with cancer. Unlike chemotherapy, ADCs are intended to target and kill only the cancer cells and spare healthy cells.
Over the next five years, LPI(LP Information) projects that Antibody-drug Conjugate will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Antibody-drug Conjugate market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibody-drug Conjugate market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Adcetris
• Kadcyla

Segmentation by application:

• Breast Cancer
• Lymphoma

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Agensys
• Concortis Biotherapeutics
• Sanofi
• Celldex Therapeutics
• Synthon Holding BV
• ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Antibody-drug Conjugate consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Antibody-drug Conjugate market by identifying its various subsegments.
• Focuses on the key global Antibody-drug Conjugate manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Antibody-drug Conjugate with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Antibody-drug Conjugate submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antibody-drug Conjugate Consumption 2013-2023
  2.1.2 Antibody-drug Conjugate Consumption CAGR by Region
2.2 Antibody-drug Conjugate Segment by Type
  2.2.1 Adcetris
  2.2.2 Kadcyla
2.3 Antibody-drug Conjugate Consumption by Type
  2.3.1 Global Antibody-drug Conjugate Consumption Market Share by Type (2013-2018)
  2.3.2 Global Antibody-drug Conjugate Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Antibody-drug Conjugate Sale Price by Type (2013-2018)
2.4 Antibody-drug Conjugate Segment by Application
  2.4.1 Breast Cancer
  2.4.2 Lymphoma
2.5 Antibody-drug Conjugate Consumption by Application
  2.5.1 Global Antibody-drug Conjugate Consumption Market Share by Application (2013-2018)
  2.5.2 Global Antibody-drug Conjugate Value and Market Share by Application (2013-2018)
  2.5.3 Global Antibody-drug Conjugate Sale Price by Application (2013-2018)

3 GLOBAL ANTIBODY-DRUG CONJUGATE BY PLAYERS

3.1 Global Antibody-drug Conjugate Sales Market Share by Players
  3.1.1 Global Antibody-drug Conjugate Sales by Players (2016-2018)
  3.1.2 Global Antibody-drug Conjugate Sales Market Share by Players (2016-2018)
3.2 Global Antibody-drug Conjugate Revenue Market Share by Players
  3.2.1 Global Antibody-drug Conjugate Revenue by Players (2016-2018)
  3.2.2 Global Antibody-drug Conjugate Revenue Market Share by Players (2016-2018)
3.3 Global Antibody-drug Conjugate Sale Price by Players
3.4 Global Antibody-drug Conjugate Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Antibody-drug Conjugate Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Antibody-drug Conjugate Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ANTIBODY-DRUG CONJUGATE BY REGIONS

4.1 Antibody-drug Conjugate by Regions
  4.1.1 Global Antibody-drug Conjugate Consumption by Regions
  4.1.2 Global Antibody-drug Conjugate Value by Regions
4.2 Americas Antibody-drug Conjugate Consumption Growth
4.3 APAC Antibody-drug Conjugate Consumption Growth
4.4 Europe Antibody-drug Conjugate Consumption Growth
4.5 Middle East & Africa Antibody-drug Conjugate Consumption Growth

5 AMERICAS

5.1 Americas Antibody-drug Conjugate Consumption by Countries
  5.1.1 Americas Antibody-drug Conjugate Consumption by Countries (2013-2018)
  5.1.2 Americas Antibody-drug Conjugate Value by Countries (2013-2018)
5.2 Americas Antibody-drug Conjugate Consumption by Type
5.3 Americas Antibody-drug Conjugate Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Antibody-drug Conjugate Consumption by Countries
  6.1.1 APAC Antibody-drug Conjugate Consumption by Countries (2013-2018)
  6.1.2 APAC Antibody-drug Conjugate Value by Countries (2013-2018)
6.2 APAC Antibody-drug Conjugate Consumption by Type
6.3 APAC Antibody-drug Conjugate Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Antibody-drug Conjugate by Countries
  7.1.1 Europe Antibody-drug Conjugate Consumption by Countries (2013-2018)
  7.1.2 Europe Antibody-drug Conjugate Value by Countries (2013-2018)
7.2 Europe Antibody-drug Conjugate Consumption by Type
7.3 Europe Antibody-drug Conjugate Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antibody-drug Conjugate by Countries
  8.1.1 Middle East & Africa Antibody-drug Conjugate Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Antibody-drug Conjugate Value by Countries (2013-2018)
8.2 Middle East & Africa Antibody-drug Conjugate Consumption by Type
8.3 Middle East & Africa Antibody-drug Conjugate Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Antibody-drug Conjugate Distributors
10.3 Antibody-drug Conjugate Customer

11 GLOBAL ANTIBODY-DRUG CONJUGATE MARKET FORECAST

11.1 Global Antibody-drug Conjugate Consumption Forecast (2018-2023)
11.2 Global Antibody-drug Conjugate Forecast by Regions
  11.2.1 Global Antibody-drug Conjugate Forecast by Regions (2018-2023)
  11.2.2 Global Antibody-drug Conjugate Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Antibody-drug Conjugate Forecast by Type
11.8 Global Antibody-drug Conjugate Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Agensys
  12.1.1 Company Details
  12.1.2 Antibody-drug Conjugate Product Offered
  12.1.3 Agensys Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Agensys News
12.2 Concortis Biotherapeutics
  12.2.1 Company Details
  12.2.2 Antibody-drug Conjugate Product Offered
  12.2.3 Concortis Biotherapeutics Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Concortis Biotherapeutics News
12.3 Sanofi
  12.3.1 Company Details
  12.3.2 Antibody-drug Conjugate Product Offered
  12.3.3 Sanofi Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Sanofi News
12.4 Celldex Therapeutics
  12.4.1 Company Details
  12.4.2 Antibody-drug Conjugate Product Offered
  12.4.3 Celldex Therapeutics Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Celldex Therapeutics News
12.5 Synthon Holding BV
  12.5.1 Company Details
  12.5.2 Antibody-drug Conjugate Product Offered
  12.5.3 Synthon Holding BV Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Synthon Holding BV News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antibody-drug Conjugate
Table Product Specifications of Antibody-drug Conjugate
Figure Antibody-drug Conjugate Report Years Considered
Figure Market Research Methodology
Figure Global Antibody-drug Conjugate Consumption Growth Rate 2013-2023 (K Units)
Figure Global Antibody-drug Conjugate Value Growth Rate 2013-2023 ($ Millions)
Table Antibody-drug Conjugate Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Adcetris
Table Major Players of Adcetris
Figure Product Picture of Kadcyla
Table Major Players of Kadcyla
Table Global Consumption Sales by Type (2013-2018)
Table Global Antibody-drug Conjugate Consumption Market Share by Type (2013-2018)
Figure Global Antibody-drug Conjugate Consumption Market Share by Type (2013-2018)
Table Global Antibody-drug Conjugate Revenue by Type (2013-2018) ($ million)
Table Global Antibody-drug Conjugate Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Antibody-drug Conjugate Value Market Share by Type (2013-2018)
Table Global Antibody-drug Conjugate Sale Price by Type (2013-2018)
Figure Antibody-drug Conjugate Consumed in Breast Cancer
Figure Global Antibody-drug Conjugate Market: Breast Cancer (2013-2018) (K Units)
Figure Global Antibody-drug Conjugate Market: Breast Cancer (2013-2018) ($ Millions)
Figure Global Breast Cancer YoY Growth ($ Millions)
Figure Antibody-drug Conjugate Consumed in Lymphoma
Figure Global Antibody-drug Conjugate Market: Lymphoma (2013-2018) (K Units)
Figure Global Antibody-drug Conjugate Market: Lymphoma (2013-2018) ($ Millions)
Figure Global Lymphoma YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Antibody-drug Conjugate Consumption Market Share by Application (2013-2018)
Figure Global Antibody-drug Conjugate Consumption Market Share by Application (2013-2018)
Table Global Antibody-drug Conjugate Value by Application (2013-2018)
Table Global Antibody-drug Conjugate Value Market Share by Application (2013-2018)
Figure Global Antibody-drug Conjugate Value Market Share by Application (2013-2018)
Table Global Antibody-drug Conjugate Sale Price by Application (2013-2018)
Table Global Antibody-drug Conjugate Sales by Players (2016-2018) (K Units)
Table Global Antibody-drug Conjugate Sales Market Share by Players (2016-2018)
Figure Global Antibody-drug Conjugate Sales Market Share by Players in 2016
Figure Global Antibody-drug Conjugate Sales Market Share by Players in 2017
Table Global Antibody-drug Conjugate Revenue by Players (2016-2018) ($ Millions)
Table Global Antibody-drug Conjugate Revenue Market Share by Players (2016-2018)
Figure Global Antibody-drug Conjugate Revenue Market Share by Players in 2016
Figure Global Antibody-drug Conjugate Revenue Market Share by Players in 2017
Table Global Antibody-drug Conjugate Sale Price by Players (2016-2018)
Figure Global Antibody-drug Conjugate Sale Price by Players in 2017
Table Global Antibody-drug Conjugate Manufacturing Base Distribution and Sales Area by Players
Table Players Antibody-drug Conjugate Products Offered
Table Antibody-drug Conjugate Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Antibody-drug Conjugate Consumption by Regions 2013-2018 (K Units)
Table Global Antibody-drug Conjugate Consumption Market Share by Regions 2013-2018
Figure Global Antibody-drug Conjugate Consumption Market Share by Regions 2013-2018
Table Global Antibody-drug Conjugate Value by Regions 2013-2018 ($ Millions)
Table Global Antibody-drug Conjugate Value Market Share by Regions 2013-2018
Figure Global Antibody-drug Conjugate Value Market Share by Regions 2013-2018
Figure Americas Antibody-drug Conjugate Consumption 2013-2018 (K Units)
Figure Americas Antibody-drug Conjugate Value 2013-2018 ($ Millions)
Figure APAC Antibody-drug Conjugate Consumption 2013-2018 (K Units)
Figure APAC Antibody-drug Conjugate Value 2013-2018 ($ Millions)
Figure Europe Antibody-drug Conjugate Consumption 2013-2018 (K Units)
Figure Europe Antibody-drug Conjugate Value 2013-2018 ($ Millions)
Figure Middle East & Africa Antibody-drug Conjugate Consumption 2013-2018 (K Units)
Figure Middle East & Africa Antibody-drug Conjugate Value 2013-2018 ($ Millions)
Table Americas Antibody-drug Conjugate Consumption by Countries (2013-2018) (K Units)
Table Americas Antibody-drug Conjugate Consumption Market Share by Countries (2013-2018)
Figure Americas Antibody-drug Conjugate Consumption Market Share by Countries in 2017
Table Americas Antibody-drug Conjugate Value by Countries (2013-2018) ($ Millions)
Table Americas Antibody-drug Conjugate Value Market Share by Countries (2013-2018)
Figure Americas Antibody-drug Conjugate Value Market Share by Countries in 2017
Table Americas Antibody-drug Conjugate Consumption by Type (2013-2018) (K Units)
Table Americas Antibody-drug Conjugate Consumption Market Share by Type (2013-2018)
Figure Americas Antibody-drug Conjugate Consumption Market Share by Type in 2017
Table Americas Antibody-drug Conjugate Consumption by Application (2013-2018) (K Units)
Table Americas Antibody-drug Conjugate Consumption Market Share by Application (2013-2018)
Figure Americas Antibody-drug Conjugate Consumption Market Share by Application in 2017
Figure United States Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure United States Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Canada Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Canada Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Mexico Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Mexico Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Table APAC Antibody-drug Conjugate Consumption by Countries (2013-2018) (K Units)
Table APAC Antibody-drug Conjugate Consumption Market Share by Countries (2013-2018)
Figure APAC Antibody-drug Conjugate Consumption Market Share by Countries in 2017
Table APAC Antibody-drug Conjugate Value by Countries (2013-2018) ($ Millions)
Table APAC Antibody-drug Conjugate Value Market Share by Countries (2013-2018)
Figure APAC Antibody-drug Conjugate Value Market Share by Countries in 2017
Table APAC Antibody-drug Conjugate Consumption by Type (2013-2018) (K Units)
Table APAC Antibody-drug Conjugate Consumption Market Share by Type (2013-2018)
Figure APAC Antibody-drug Conjugate Consumption Market Share by Type in 2017
Table APAC Antibody-drug Conjugate Consumption by Application (2013-2018) (K Units)
Table APAC Antibody-drug Conjugate Consumption Market Share by Application (2013-2018)
Figure APAC Antibody-drug Conjugate Consumption Market Share by Application in 2017
Figure China Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure China Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Japan Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Japan Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Korea Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Korea Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure India Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure India Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Australia Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Australia Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Table Europe Antibody-drug Conjugate Consumption by Countries (2013-2018) (K Units)
Table Europe Antibody-drug Conjugate Consumption Market Share by Countries (2013-2018)
Figure Europe Antibody-drug Conjugate Consumption Market Share by Countries in 2017
Table Europe Antibody-drug Conjugate Value by Countries (2013-2018) ($ Millions)
Table Europe Antibody-drug Conjugate Value Market Share by Countries (2013-2018)
Figure Europe Antibody-drug Conjugate Value Market Share by Countries in 2017
Table Europe Antibody-drug Conjugate Consumption by Type (2013-2018) (K Units)
Table Europe Antibody-drug Conjugate Consumption Market Share by Type (2013-2018)
Figure Europe Antibody-drug Conjugate Consumption Market Share by Type in 2017
Table Europe Antibody-drug Conjugate Consumption by Application (2013-2018) (K Units)
Table Europe Antibody-drug Conjugate Consumption Market Share by Application (2013-2018)
Figure Europe Antibody-drug Conjugate Consumption Market Share by Application in 2017
Figure Germany Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Germany Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure France Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure France Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure UK Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure UK Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Italy Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Italy Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Russia Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Russia Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Spain Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Spain Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Antibody-drug Conjugate Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Antibody-drug Conjugate Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Antibody-drug Conjugate Consumption Market Share by Countries in 2017
Table Middle East & Africa Antibody-drug Conjugate Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Antibody-drug Conjugate Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Antibody-drug Conjugate Value Market Share by Countries in 2017
Table Middle East & Africa Antibody-drug Conjugate Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Antibody-drug Conjugate Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Antibody-drug Conjugate Consumption Market Share by Type in 2017
Table Middle East & Africa Antibody-drug Conjugate Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Antibody-drug Conjugate Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Antibody-drug Conjugate Consumption Market Share by Application in 2017
Figure Egypt Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Egypt Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure South Africa Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure South Africa Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Israel Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Israel Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure Turkey Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure Turkey Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Antibody-drug Conjugate Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Antibody-drug Conjugate Value Growth 2013-2018 ($ Millions)
Table Antibody-drug Conjugate Distributors List
Table Antibody-drug Conjugate Customer List
Figure Global Antibody-drug Conjugate Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Antibody-drug Conjugate Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Antibody-drug Conjugate Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Antibody-drug Conjugate Consumption Market Forecast by Regions
Table Global Antibody-drug Conjugate Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Antibody-drug Conjugate Value Market Share Forecast by Regions
Figure Americas Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Americas Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure APAC Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure APAC Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Europe Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Europe Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Middle East & Africa Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Middle East & Africa Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure United States Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure United States Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Canada Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Canada Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Mexico Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Mexico Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Brazil Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Brazil Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure China Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure China Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Japan Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Japan Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Korea Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Korea Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Southeast Asia Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Southeast Asia Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure India Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure India Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Australia Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Australia Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Germany Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Germany Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure France Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure France Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure UK Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure UK Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Italy Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Italy Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Russia Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Russia Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Spain Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Spain Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Egypt Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Egypt Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure South Africa Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure South Africa Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Israel Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Israel Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure Turkey Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure Turkey Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Figure GCC Countries Antibody-drug Conjugate Consumption 2018-2023 (K Units)
Figure GCC Countries Antibody-drug Conjugate Value 2018-2023 ($ Millions)
Table Global Antibody-drug Conjugate Consumption Forecast by Type (2018-2023) (K Units)
Table Global Antibody-drug Conjugate Consumption Market Share Forecast by Type (2018-2023)
Table Global Antibody-drug Conjugate Value Forecast by Type (2018-2023) ($ Millions)
Table Global Antibody-drug Conjugate Value Market Share Forecast by Type (2018-2023)
Table Global Antibody-drug Conjugate Consumption Forecast by Application (2018-2023) (K Units)
Table Global Antibody-drug Conjugate Consumption Market Share Forecast by Application (2018-2023)
Table Global Antibody-drug Conjugate Value Forecast by Application (2018-2023) ($ Millions)
Table Global Antibody-drug Conjugate Value Market Share Forecast by Application (2018-2023)
Table Agensys Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Agensys Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Agensys Antibody-drug Conjugate Market Share (2016-2018)
Table Concortis Biotherapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Concortis Biotherapeutics Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Concortis Biotherapeutics Antibody-drug Conjugate Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Antibody-drug Conjugate Market Share (2016-2018)
Table Celldex Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celldex Therapeutics Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Celldex Therapeutics Antibody-drug Conjugate Market Share (2016-2018)
Table Synthon Holding BV Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Synthon Holding BV Antibody-drug Conjugate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Synthon Holding BV Antibody-drug Conjugate Market Share (2016-2018)